Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A vaccine study involving healthy adults

You are invited to take part in a study investigating a new vaccine against Respiratory Syncytial Virus (RSV).  The study is being run by the Oxford Vaccine Group which is part of the University of Oxford.

Please get in touch if you:

·      are aged 18 to 45 years old and in good health

·      are able to attend visits at the Churchill Hospital, Oxford

·      are interested in preventing a major cause of global infant deaths


We will provide reimbursement for your time, inconvenience and travel. The total study participation time is 1 year.


Before you decide whether you would like to take part, it is important for you to understand exactly what the study is about and what participation would involve.  If you would like to read more about the study and see if you are you eligible to take part, please go to here.


If you would like to discuss the study further, please contact us:

Telephone: 01865 857420

Email: info@ovg.ox.ac.uk